NanoFIRE: A NanoLuciferase and Fluorescent Integrated Reporter Element for Robust and Sensitive Investigation of HIF and Other Signalling Pathways.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
19 10 2023
Historique:
received: 28 09 2023
revised: 16 10 2023
accepted: 16 10 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

The Hypoxia Inducible Factor (HIF) transcription factors are imperative for cell adaption to low oxygen conditions and development; however, they also contribute to ischaemic disease and cancer. To identify novel genetic regulators which target the HIF pathway or small molecules for therapeutic use, cell-based reporter systems are commonly used. Here, we present a new, highly sensitive and versatile reporter system, NanoFIRE: a NanoLuciferase and Fluorescent Integrated Reporter Element. Under the control of a Hypoxic Response Element (HRE-NanoFIRE), this system is a robust sensor of HIF activity within cells and potently responds to both hypoxia and chemical inducers of the HIF pathway in a highly reproducible and sensitive manner, consistently achieving 20 to 150-fold induction across different cell types and a Z' score > 0.5. We demonstrate that the NanoFIRE system is adaptable via substitution of the response element controlling NanoLuciferase and show that it can report on the activity of the transcriptional regulator Factor Inhibiting HIF, and an unrelated transcription factor, the Progesterone Receptor. Furthermore, the lentivirus-mediated stable integration of NanoFIRE highlights the versatility of this system across a wide range of cell types, including primary cells. Together, these findings demonstrate that NanoFIRE is a robust reporter system for the investigation of HIF and other transcription factor-mediated signalling pathways in cells, with applications in high throughput screening for the identification of novel small molecule and genetic regulators.

Identifiants

pubmed: 37892227
pii: biom13101545
doi: 10.3390/biom13101545
pmc: PMC10605489
pii:
doi:

Substances chimiques

Transcription Factors 0
Nuclear Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Mol Biol. 2016 Sep 25;428(19):3831-49
pubmed: 27380738
Anal Biochem. 2005 Jan 1;336(1):125-31
pubmed: 15582567
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2301-6
pubmed: 17284606
Contrast Media Mol Imaging. 2018 Dec 3;2018:2514796
pubmed: 30627058
J Biol Chem. 2000 Aug 18;275(33):25130-8
pubmed: 10833514
Nucleic Acids Res. 2023 Jul 7;51(12):5981-5996
pubmed: 37099375
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2622-7
pubmed: 18268343
Nat Methods. 2018 Jan;15(1):47-51
pubmed: 29320486
Curr Opin Chem Biol. 2010 Jun;14(3):315-24
pubmed: 20417149
J Cell Biochem. 2015 May;116(5):696-703
pubmed: 25546605
Cancer Immunol Res. 2021 Apr;9(4):401-414
pubmed: 33602720
Nat Rev Cancer. 2003 Oct;3(10):721-32
pubmed: 13130303
J Biomol Screen. 1999;4(2):67-73
pubmed: 10838414
Biochem J. 2004 Aug 1;381(Pt 3):761-7
pubmed: 15104534
Mol Imaging. 2013 Oct;12(7):1-13
pubmed: 24371848
J Am Chem Soc. 2005 Jun 1;127(21):7680-1
pubmed: 15913349
ACS Chem Biol. 2008 Aug 15;3(8):463-70
pubmed: 18590332
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8386-91
pubmed: 10880563
Nat Methods. 2005 Dec;2(12):905-9
pubmed: 16299475
Cells. 2022 May 05;11(9):
pubmed: 35563869
Front Oncol. 2013 Jul 29;3:199
pubmed: 23914349
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
J Med Chem. 2022 Sep 8;65(17):11415-11432
pubmed: 36018000
Elife. 2017 Mar 15;6:
pubmed: 28296633
Mol Cancer Ther. 2008 Jan;7(1):90-100
pubmed: 18202012
Neoplasia. 2015 Dec;17(12):871-881
pubmed: 26696369
Clin Chim Acta. 2019 Feb;489:225-232
pubmed: 30107158
J Biol Chem. 2004 Sep 10;279(37):38458-65
pubmed: 15247232
Nat Methods. 2020 Aug;17(8):852-860
pubmed: 32661427
Cell Metab. 2018 Apr 3;27(4):898-913.e7
pubmed: 29617647
JCI Insight. 2023 Oct 23;8(20):
pubmed: 37707961
Cell. 2001 Oct 5;107(1):43-54
pubmed: 11595184
Bioconjug Chem. 2016 May 18;27(5):1175-1187
pubmed: 27045664
Chem Biol Interact. 2011 May 30;191(1-3):206-16
pubmed: 21182832
Trends Cell Biol. 2009 Nov;19(11):649-55
pubmed: 19819147
Anal Chem. 2021 Nov 2;93(43):14462-14470
pubmed: 34677954
Genes Dev. 2002 Jun 15;16(12):1466-71
pubmed: 12080085
J Biol Chem. 2000 Sep 22;275(38):29643-7
pubmed: 10882714
EMBO J. 2016 Jan 4;35(1):102-13
pubmed: 26598532
Cell Metab. 2010 May 5;11(5):364-78
pubmed: 20399150
Chem Biol. 2010 Jun 25;17(6):646-57
pubmed: 20609414
J Med Chem. 2018 Nov 8;61(21):9691-9721
pubmed: 30289716
Mol Cell Biol. 2003 Dec;23(24):9361-74
pubmed: 14645546
Cancer Res. 2005 Jun 1;65(11):4918-28
pubmed: 15930314
J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):67-77
pubmed: 8603049
Chem Sci. 2017 Nov 1;8(11):7651-7668
pubmed: 29435217
Mol Cancer Ther. 2004 Mar;3(3):233-44
pubmed: 15026543
ACS Chem Biol. 2012 Nov 16;7(11):1848-57
pubmed: 22894855
J Biol Chem. 2023 Apr;299(4):104599
pubmed: 36907438
Cancer Res. 2016 Sep 15;76(18):5491-500
pubmed: 27635045
J Biol Chem. 2006 Aug 11;281(32):22575-85
pubmed: 16760477
Exp Mol Med. 2019 Jun 20;51(6):1-13
pubmed: 31221962
Dev Biol. 1999 May 15;209(2):254-67
pubmed: 10328919
Biomedicines. 2018 May 17;6(2):
pubmed: 29772792
Methods Mol Biol. 2016;1473:23-31
pubmed: 27518620
PLoS One. 2015 Mar 13;10(3):e0116373
pubmed: 25768837
Gene. 2005 Apr 25;350(1):89-98
pubmed: 15794924

Auteurs

Alison E Roennfeldt (AE)

School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.
Robinson Research Institute, School of Biomedicine, The University of Adelaide, Adelaide, SA 5006, Australia.

Timothy P Allen (TP)

School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.

Brooke N Trowbridge (BN)

School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.
Research Centre for Infectious Diseases, School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.

Michael R Beard (MR)

School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.
Research Centre for Infectious Diseases, School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.

Murray L Whitelaw (ML)

School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.
ASEAN Microbiome Nutrition Centre, National Neuroscience Institute, Singapore 169857, Singapore.

Darryl L Russell (DL)

Robinson Research Institute, School of Biomedicine, The University of Adelaide, Adelaide, SA 5006, Australia.

David C Bersten (DC)

Robinson Research Institute, School of Biomedicine, The University of Adelaide, Adelaide, SA 5006, Australia.

Daniel J Peet (DJ)

School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH